Ukraine

Ukraine

HBV elimination goal
Yes
Year of HBV elimination goal
No data
HBV Action Plan
In Development
HCV elimination goal
Yes
Year of HCV elimination goal
No data
HCV Action Plan
In Development
Prevalence
Prevalence of chronic HBV (HBsAg+) (%)
1.5
2020 , Survey/reported
Ukraine Ministry of Health, Public Health Center. (2021). Report: Viral Hepatitis 2020. [Ukranian].
Prevalence of chronic HBV (HBsAg+), Children < 5 yrs
No data
Prevalence
Prevalence of anti-HCV (%)
68.4
2020 , Modelled
Harm Reduction International. (2022). The Global State of Harm Reduction 2022. London: Harm Reduction International..
Prevalence of chronic HCV (RNA+/cAg), Persons who inject drugs
No data
Mortality
HBV-related death rate (per 100,000)
8.63
2019 , Modelled
(6 - 10)
Institute of Health Metrics and Evaluation (IHME). Global burden of Disease Study 2019
Mortality
HCV-related death rate (per 100,000)
9.76
2019 , Modelled
(7 - 12)
Institute of Health Metrics and Evaluation (IHME). Global burden of Disease Study 2019
Diagnosed & treated
Proportion of persons living with HBV diagnosed (%)
9
2022 , Modelled
Razavi-Shearer D, Gamkrelidze I, Pan C, et al. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. The Lancet Gastroenterology & Hepatology. 2023;8(10):879-907. doi:10.1016/S2468-1253(23)00197-8
Proportion of diagnosed persons receiving appropriate HBV treatment (%) (among those eligible)
1
2022 , Modelled
Center for Disease Analysis. Polaris Observatory: Ukraine. Last accessed 9 June 2023.
Diagnosed & treated
Proportion of persons living with HCV diagnosed (%)
7
2022 , Survey/reported
Communication with National Public Health Center, Ministry of Health Ukraine on 14 June 2023
Proportion of diagnosed persons who have initiated HCV treatment (%)
1
2022 , Modelled
CDA Foundation. Polaris Observatory: Ukraine. Last accessed 9 June 2023.
HepB newborn vaccination
Coverage of HepB birth dose (%)
53
2022 , Survey/reported
WHO/UNICEF Joint Reporting Form on Immunization (JRF), Last Accessed 24 January 2024
Harm reduction
Number of needles-syringes per PWID per year
41
2021 , Survey/reported
UNAIDS. AIDSinfo: Country Factsheets, Ukraine 2021. Last accessed. 9 June 2023.
Key policy indicators
HBV screening recommendations for pregnant women
Adopted
No patient co-pays for HBsAg testing
Not Adopted
Key policy indicators
National policy for harm reduction for persons who inject drugs
Adopted
No patient co-pays for anti-HCV testing
Partially Adopted
Simplified HCV care: Non-specialists can prescribe treatment
Adopted
Year Value Type Source
Equity
Indicator Status Notes
Decriminalization of drug use Not Adopted
Ukraine National Hepatitis Elimination Profile
National anti-discrimination law protecting persons living with hepatitis No Data
Ukraine National Hepatitis Elimination Profile
National policy for adult HBV vaccination Not Adopted
Ukraine National Hepatitis Elimination Profile
National policy for harm reduction for persons who inject drugs Adopted
Ukraine National Hepatitis Elimination Profile
National policy for syringe exchange in federal prisons Not Adopted
Ukraine National Hepatitis Elimination Profile
National strategy addresses key populations Partially Adopted
Ukraine National Hepatitis Elimination Profile
Prevention of mother-to-child transmission
Indicator Status Notes
Elimination of HBV mother to child transmission goal Yes
Ukraine National Hepatitis Elimination Profile
HBV screening recommendations for pregnant women Adopted
Ukraine National Hepatitis Elimination Profile
Universal HepB birth dose policy within 24 hrs of birth Adopted
Ukraine National Hepatitis Elimination Profile
Strategic information
Indicator Status Notes
Estimates of HBV economic burden Not Adopted
Ukraine National Hepatitis Elimination Profile
National HBV prevalence survey within last 5 years Partially Adopted
Ukraine National Hepatitis Elimination Profile
Routine official reporting of HBV incidence Not Adopted
Ukraine National Hepatitis Elimination Profile
Routine official reporting of HBV mortality Not Adopted
Ukraine National Hepatitis Elimination Profile
System to monitor HBV diagnosis and treatment Not Adopted
Ukraine National Hepatitis Elimination Profile
Financing
Indicator Status Notes
GFTAM funds used for HBV and/or HCV testing and treatment or harm reduction Adopted
Ukraine National Hepatitis Elimination Profile
Public budget line for HBV testing and treatment Adopted
Ukraine National Hepatitis Elimination Profile
National planning
Indicator Status Notes
HBV Action Plan In Development
Ukraine National Hepatitis Elimination Profile
HBV elimination goal Yes
Ukraine National Hepatitis Elimination Profile
Screening
Indicator Status Notes
HBV age-based or birth-cohort screening recommendations Not Adopted
Ukraine National Hepatitis Elimination Profile
HBV risk-based screening recommendations Not Adopted
Ukraine National Hepatitis Elimination Profile
HBV universal screening recommendations Not Adopted
Ukraine National Hepatitis Elimination Profile
No patient co-pays for HBsAg testing Not Adopted
Ukraine National Hepatitis Elimination Profile
Access to testing and medicines
Indicator Status Notes
Licensed point-of-care PCR testing to detect HBV Adopted
Ukraine National Hepatitis Elimination Profile
Treatment
Indicator Status Notes
National HBV treatment guidelines Developed
Ukraine National Hepatitis Elimination Profile
Simplified HBV care: No treatment co-pays Partially Adopted
Ukraine National Hepatitis Elimination Profile
Simplified HBV care: Treatment and monitoring algorithm for primary care providers No Data
Ukraine National Hepatitis Elimination Profile
Year Value Type Source
Year Value Type Source
Equity
Indicator Status Notes
Decriminalization of drug use Not Adopted
Ukraine National Hepatitis Elimination Profile
Decriminalization of possession of syringes and paraphernalia Not Adopted
Ukraine National Hepatitis Elimination Profile
National anti-discrimination law protecting persons living with hepatitis No Data
Ukraine National Hepatitis Elimination Profile
National policy for harm reduction for persons who inject drugs Adopted
Ukraine National Hepatitis Elimination Profile
National policy for syringe exchange in federal prisons Not Adopted
Ukraine National Hepatitis Elimination Profile
National strategy addresses key populations Partially Adopted
Ukraine National Hepatitis Elimination Profile
Access to testing and medicines
Indicator Status Notes
Eligible for HCV generic medicines Eligible
Ukraine National Hepatitis Elimination Profile
Licensed point-of-care PCR testing to detect HCV Adopted
Ukraine National Hepatitis Elimination Profile
Registration of HCV generic medicines Adopted
Ukraine National Hepatitis Elimination Profile
Registration of HCV originator medicines Adopted
Ukraine National Hepatitis Elimination Profile
Strategic information
Indicator Status Notes
Estimates of HCV economic burden Partially Adopted
Ukraine National Hepatitis Elimination Profile
National HCV prevalence survey within last 5 years Partially Adopted
Ukraine National Hepatitis Elimination Profile
Routine official reporting of HCV incidence Not Adopted
Ukraine National Hepatitis Elimination Profile
Routine official reporting of HCV mortality Not Adopted
Ukraine National Hepatitis Elimination Profile
System to monitor HCV diagnosis and treatment Partially Adopted
Ukraine National Hepatitis Elimination Profile
Financing
Indicator Status Notes
GFTAM funds used for HBV and/or HCV testing and treatment or harm reduction Adopted
Ukraine National Hepatitis Elimination Profile
Public budget line for HCV testing and treatment Adopted
Ukraine National Hepatitis Elimination Profile
National planning
Indicator Status Notes
HCV Action Plan In Development
Ukraine National Hepatitis Elimination Profile
HCV elimination goal Yes
Ukraine National Hepatitis Elimination Profile
Screening
Indicator Status Notes
HCV age-cohort or birth-cohort screening recommendations Not Applicable
Ukraine National Hepatitis Elimination Profile
HCV risk-based screening recommendations Adopted
Ukraine National Hepatitis Elimination Profile
HCV universal screening recommendations Adopted
Ukraine National Hepatitis Elimination Profile
No patient co-pays for anti-HCV testing Partially Adopted
Ukraine National Hepatitis Elimination Profile
Prevention of mother-to-child transmission
Indicator Status Notes
HCV screening recommendations for pregnant women Adopted
Ukraine National Hepatitis Elimination Profile
Treatment
Indicator Status Notes
National HCV treatment guidelines Developed
Ukraine National Hepatitis Elimination Profile
Simplified HCV care: Less than 2 clinic visits during treatment Not Adopted
Ukraine National Hepatitis Elimination Profile
Simplified HCV care: No fibrosis restrictions Adopted
Ukraine National Hepatitis Elimination Profile
Simplified HCV care: No genotyping requirements Adopted
Ukraine National Hepatitis Elimination Profile
Simplified HCV care: No sobriety restrictions Adopted
Ukraine National Hepatitis Elimination Profile
Simplified HCV care: No treatment co-pays Adopted
Ukraine National Hepatitis Elimination Profile
Simplified HCV care: Non-specialists can prescribe treatment Adopted
Ukraine National Hepatitis Elimination Profile
Year Value Type Source
Page last updated: 19 January 2024